Request Brochure

Covid 19 – We are fully operational during this time, taking calls 8am-8pm 7 days a week.

Thalassemia patient cured by umbilical cord blood transplantation


TEHRAN, Aug. 16 (MNA) – Umbilical cord blood stem cells of a girl was used to treat his brother’s thalassemia.

An Iranian younger sister’s umbilical cord blood stem cells which were stored in Royan Cord Blood Bank (RCBB) were used to save her 6-year-old brother suffering from thalassemia.

The successful transplantation happened when the doctors of Shariati Hospital realized the only way to treat the patient is to use his 2-year-old sister’s stem cells saved since her birthday in RCBB.

Now, after several months of transplantation, the outcome evaluation is very satisfactory and hematological values of the patient is completely normal.

Umbilical cord blood is blood that remains in the placenta and in the attached umbilical cord after childbirth. Cord blood is collected because it contains stem cells, which can be used to treat hematopoietic and genetic disorders in the future.

Click here to find out more

stem cell preservation

BSc (Hons) Microbiology

Chief Executive Officer | Biovault Family

Biovault Family CEO, Kate Sneddon, joined Biovault in July 2009 and became Chief Executive Officer in 2016. As health industry professional her experience includes working as a microbiologist and leader at GSK for over 10 years. Her expertise in cord blood banking has been recognised in her awards, features in Parliamentary Review and Parents Guide to Cord Blood, as well as contributions to research with UCL and others.


Share This Article:


Categories:


Tags:

Request a Brochure

Find out more.

Our hope is that the information in this brochure will empower you as you weigh-up your cord blood and tissue storage options and prepare for your family’s healthy future.

Download your free guide to Biovault Family's cord blood banking!